Luminous VenturesLuminous shares boards and has co-invested alongside leading investors such as Khosla Ventures, Draper Esprit, Iconiq, Founders Fund, Hoxton Ventures, Speedinvest, Inovia, Horizons Ventures, Sofinnova, CTI Life Sciences, OSI and IQ Capital.
Biomage Ltd
Fathom ComputingLuminous has invested in 2025 companies, with many emerging from top university ecosystems such as Oxford, Imperial and University College London. Companies include Synthace, developing a revolutionary new operating system for laboratories; Hadean, building a new high-performance operating system for the cloud; Optellum, developing an AI-based diagnostic for lung cancer; Vital Biosciences, designing a new generation of tools to empower individuals in monitoring their health and managing disease; Ellipsis Health, a new AI-based diagnostic for mental health; Universal Quantum, building a universal quantum computer, Phenomic AI, leveraging deep learning and co-culture cell models to discover new cancer drugs; Climax Foods, using data science to transform plants into foods that we love. Luminous Ventures spun out of White Cloud Capital in 2018.